Full-Time

Value Stream Manager

Posted on 5/13/2026

Integra LifeSciences

Integra LifeSciences

1,001-5,000 employees

Regenerative medicine, surgical devices provider

Compensation Overview

$95k - $130k/yr

+ Bonus + Commission + Equity

Cincinnati, OH, USA

In Person

Category
Biology & Biotech (1)
Requirements
  • Engineering or Technical degree with 8+ years of experience leading a team (direct reports or projects) or equivalent education and years of management experience
  • Master degree with 5+ years of experience leading a team (direct reports or projects) or equivalent education and years of management experience
  • Demonstrate excellent organizational and English communication skills (oral & written)
  • Financial acumen relating to operations profit & loss items
  • Proficiency in MS Office Suite and statistical analysis software
  • Experience in regulated environment; medical device or pharma preferred
  • Familiarity with health, safety, and environmental regulations related to manufacturing
  • Self-motivated team player with ability to work independently and collaboratively across all levels of the organization
Responsibilities
  • Ensures the safety of colleagues through effective and continuously improving environmental, health, and safety program engagement. Ensure all team members receive training, and are knowledgeable and compliant regarding safety procedures, policies, permits, practices, PPE, proper housekeeping, and awareness. Initiates and lead accident, near miss, and incident event notifications.
  • Lead, coach, and develop a team of technicians, operators, managers, supervisors, and process engineers.
  • Responsible for managing staffing, training and daily maintenance operations across shifts up to 7 days a week, including attendance, overtime, operational issues, talent management, performance management, development planning and reporting of results. Interviews job candidates, completes performance reviews, and justifies promotions or disciplinary actions (as appropriate).
  • Serve as a member of the site leadership team participating in strategic and tactical planning & execution to ensure site objectives are met. Ensure alignment of value stream objectives with overall site objectives.
  • Foster a culture of colleague engagement through positive leadership, recognition, accountability, feedback, continuous improvement, and engagement activities
  • Responsible for the team’s compliance and meeting the quality standards as defined by Integra’s SOPs, GMPs, Global Quality Standards, local and procedures, where applicable. Partner with Quality Assurance and Regulatory Affairs to ensure full compliance with applicable standards (FDA QSR, GMP, ISO 13485, etc).
  • Initiate, develop and implement engineering studies and IQ/OQ/PQ/TMV validations for equipment and processes to meet the demands of new product introductions and current manufacturing operations. Coordinate specific efforts as required by the project team. Includes such tasks as development of manufacturing process requirements, specifications, Failure Mode Effects Analysis (FMEA), validations, Engineering Change Requests/Orders (ECR/ECO) and Engineering Drawings.
  • Ensures investigations/CAPAs/nonconformances identify root cause, are appropriately corrected with sustainable remediations. Leverage data/tools/techniques to identify root causes and implement sustainable corrective actions.
  • Ensure training and process documentation requirements are consistently met.
  • Partner with supplier quality and procurement to ensure supplier issues and changes are addressed appropriately within quality management system in a timely manner.
  • Coach/mentor lean six-sigma manufacturing initiatives (5S, Kaizen, Value Stream Mapping, Kanban, Standard Work. OEE) to reduce waste and improve flow across the value stream.
  • Ensure teams delivering measurable improvements in yield, throughput, and cycle time across the value streams in line with KPI targets.
  • Partner with the cross-functional teams to meet customer fulfillment needs as well as lead process optimization, yield improvement, six sigma process excellence and lean projects. Monitor process capability and performance metrics (CoPQ,Cpk, yield, run time, downtime, scrap). Develop process/project improvement and mitigation projects to improve capability and performance.
  • Develops, reviews, approves, and accountable for all financial budgets within the value stream, including headcount, expense, capital, and inventory.
  • Ensure value stream cost of goods sold (COGS) results are in line with financial targets by ensuring bill-of-materials (BOMS), routers, and process instructions align to costs.
  • Work cross-functionally and collaboratively to solve operational issues. Interacts with senior management on matters concerning several job areas, departments, and/or customers to accept new concepts, practices and approaches as well as with senior level vendor or customer representatives concerning projects & operational decisions.
  • Complete other job-related duties as assigned.

Integra LifeSciences develops medical technologies for tissue repair and regeneration, including tissue-regeneration scaffolds, neurosurgical devices, wound care products, and specialized surgical instruments. Its scaffolds are implanted on wounds to provide a temporary matrix that guides new tissue growth and gradually integrates with the patient's tissue. The company differentiates itself through a diversified, multi-domain portfolio built via acquisitions, spanning regenerative medicine and conventional medical devices. Its goal is to broaden access to regenerative technology and raise standards of care in surgery and tissue repair.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Plainsboro Township, New Jersey

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $392 million, beating guidance with 1.3% organic growth.
  • Raised 2026 adjusted EPS guidance to $2.40-$2.50 on tariff benefits and demand.
  • Braintree facility launches June 2026, enabling SurgiMend Q4 relaunch and supply resilience.

What critics are saying

  • Codman perforator recall causes 10 injuries, triggers lawsuits and hospital product bans.
  • FDA warning letter enforces $27 million ship holds, delaying PriMatrix and neurosurgery revenue.
  • Medline captures 20-30% neurosurgery drill market share with defect-free craniotomy kits.

What makes Integra LifeSciences unique

  • Pioneered regenerative medicine with 1996 FDA-approved Integra Artificial Skin from MIT technology.
  • Expands neurosurgery portfolio with Durepair Dura Regeneration Matrix and Mayfield Ghost Base Unit.
  • Diversified across neurosurgery, wound care, and surgical reconstruction via strategic acquisitions.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Integra LifeSciences who can refer or advise you

Benefits

Medical Insurance

Dental Insurance

Vision Insurance

Short-Term Disability

Long-Term Disability

401(k) Retirement Plan

Company News

Yahoo Finance
Feb 26th, 2026
Integra LifeSciences sees 0.7% organic revenue decline in 2025, guides to $1.66B–1.7B for 2026

Integra LifeSciences reported Q4 revenue of $435 million and adjusted earnings per share above guidance midpoint, but faces headwinds in 2025. Full-year revenue reached $1.635 billion with 0.7% organic decline, whilst gross margin fell 260 basis points to 61.9% due to tariffs, quality remediation and supply constraints. For 2026, the company guided revenue of $1.66 billion to $1.7 billion and adjusted EPS of $2.30 to $2.40, excluding potential new tariff impacts. Management expects operating cash flow exceeding $200 million and plans to reduce leverage from 4.5 times to 2.5–3.5 times by year-end. The company highlighted operational improvements including a new operating model, supply-chain resilience and early relaunches of PriMatrix and DuraRepair. A Braintree facility launching by June should support SurgiMend's Q4 2026 return.

Yahoo Finance
Feb 26th, 2026
Integra LifeSciences shares fall 3.5% on weak Q1 revenue forecast despite Q4 beat

Integra LifeSciences shares fell 3.5% after the medical device company issued weak revenue guidance for the first quarter and reported a significant drop in profitability. The company forecast first-quarter revenue of $382.5 million, 2.8% below analyst expectations. Whilst fourth-quarter revenue of $434.9 million and adjusted earnings per share of $0.83 beat expectations, underlying metrics showed deterioration. Revenue declined 1.7% year-over-year, operating margin fell sharply to 5.3% from 14.5% the previous year, and free cash flow was negative $5.4 million compared to positive $21.14 million a year ago. The combination of weak outlook and deteriorating profitability overshadowed the headline beats. Shares are down 6.9% year-to-date and trading 53.3% below their 52-week high.

Yahoo Finance
Feb 26th, 2026
Integra LifeSciences Q4 sales beat estimates but Q1 guidance misses by 2.8%

Integra LifeSciences reported Q4 2025 revenue of $434.9 million, beating analyst estimates by 1% but declining 1.7% year on year. The medical device company's adjusted earnings per share of $0.83 exceeded expectations by 3.7%. However, the company's Q1 2026 revenue guidance of $382.5 million fell 2.8% below analyst estimates. Operating margin dropped to 5.3% from 14.5% in the prior year quarter, whilst free cash flow turned negative at -$5.4 million. Founded in 1989, Integra develops medical technologies for neurosurgery, wound care and surgical reconstruction. The company has struggled with tepid growth, recording just 3.6% compound annual revenue growth over five years. Its organic revenue rose 2.5% year on year in the quarter.

Yahoo Finance
Feb 25th, 2026
Integra LifeSciences to report Q4 earnings tomorrow amid 2.7% revenue decline forecast

Medical device company Integra LifeSciences will report earnings tomorrow, with analysts expecting revenue to decline 2.7% year on year, reversing an 11.5% increase from the same quarter last year. The company missed revenue expectations last quarter, reporting $402.1 million in revenues, up 5.6% year on year. It also significantly missed revenue guidance for the following quarter. Integra has missed Wall Street's revenue estimates multiple times over the past two years. Analysts have generally reconfirmed their estimates over the last 30 days. Integra's shares are up 5.7% over the past month, outperforming the healthcare equipment segment's 1.9% decline. The stock currently trades at $11.70 against an average analyst price target of $15.50.

DECCO, Inc.
Nov 13th, 2025
DECCO Recognized for "Excellence in Construction"

DECCO recognized for "Excellence in Construction" WOBURN, MA - The Massachusetts Chapter of Associated Builders and Contractors (ABC MA) congratulates DECCO for earning an Eagle Award at the 33rd annual Excellence in Construction Awards for their outstanding work on Integra Life Sciences' Project Revere. Nearly 250 ABC members gathered at the Four Points by Sheraton Hotel in Norwood on November 6th to recognize and celebrate the very best construction projects their companies have to offer. This year's applicant pool was particularly competitive, with each winner selected for the high standards of craftsmanship, safety and quality delivered by talented merit shop workers using the efficient merit shop approach. "We are proud to recognize the outstanding work of our member contractors through the ABC Excellence in Construction Awards," said ABC MA President Greg Beeman. "The winning contractors maintained a constant focus on meeting their clients' needs and set a high bar for craftsmanship, quality and safety." The Eagle Award DECCO won for Project Revere is the pinnacle of achievement. It recognizes overall excellence in project execution, craftsmanship, safety, innovative elements and challenges, and client satisfaction. The Massachusetts Chapter of Associated Builders and Contractors is the largest construction trade association in the Commonwealth, representing nearly 500 local general contractor, subcontractor, supplier and associate members that employ over 20,000 workers throughout Massachusetts.